A total of 399 patients with meningiomas were identified, and 2.5% (n = 10) had alterations in PBRM1. Of the 10 patients with PBRM1 alterations, one patient had a known pathogenic point mutation variant (R1027X). This evidence concerns the gene PBRM1 and meningioma.